GlassScriptPhysician profile
Eileen C West
NPI 1366411639
$3,425.43
in general payments reported to CMS, 2019-2025
19 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $348 · 2021: $398 · 2022: $1,203 · 2023: $218 · 2024: $730 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.44 |
| Education | $210.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,050.00 | 2022 | |
| Amgen INC. | $433.35 | 2020-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $416.79 | 2022-2024 | Veozah |
| Lilly USA, LLC | $345.36 | 2021-2025 | Zepbound, Mounjaro |
| Renovia INC | $236.51 | 2021 | |
| Novo Nordisk INC | $231.37 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $145.61 | 2021-2025 | |
| Therapeuticsmd, INC. | $138.27 | 2019-2020 | |
| Radius Health, INC. | $119.88 | 2020-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $58.24 | 2024 | |
| Hologic Sales and Service, LLC | $43.49 | 2020 | |
| Glaxosmithkline, LLC. | $41.75 | 2020-2023 | Shingrix, Arexvy |
| Mayne Pharma Commercial LLC | $41.23 | 2025 | |
| Dynavax Technologies Corporation | $31.18 | 2022 | |
| Aspira Women'S Health INC | $24.25 | 2023 | Ova1 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $22.49 | 2020 | |
| Hikma Pharmaceuticals USA | $16.31 | 2020 | |
| Exact Sciences Corporation | $15.43 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.